The Drug Enforcement Administration (DEA) was first established in 1973 and is an investigative / enforcement component of the U.S. Department of Justice. The DEA is the primary federal agency that has been tasked with the enforcement of laws governing the illegal sale, distribution, manufacturing or use of drugs. The primary statute enforced by the DEA is the Controlled Substances Act (CSA). The CSA sets out Federal drug policy with respect to both legal (pharmaceutical) and illegal controlled substances and essentially serves as the legal cornerstone of our nation’s ongoing efforts to regulate the safe manufacture, distribution, importation, possession and use of drugs and controlled substances. Furthermore, the DEA is responsible for ensuring that controlled substances are strictly monitored and regulated so that any transactions involving controlled substances take placed with the “Closed System” of distribution. Under this closed system:
“. . . all legitimate handlers of controlled substances – manufacturers, distributors, physicians, pharmacies, and researchers – must be registered with DEA and maintain strict accounting for all distributions.”
I. The Interplay Between Federal and State Controlled Substances Laws:
Federal controlled substances laws are intended to work in conjunction with State controlled substance statutes. DEA agents, investigators and enforcement staff work closely with their State, county and local counterparts to safeguard the public and to make sure that pharmaceutical controlled substances are only prescribed, administered, dispensed and used for legitimate medical purposes in accordance with applicable federal and state laws. DEA representatives also work closely with state professional licensing boards responsible for regulating the actions of physicians, nurse practitioners, physician assistants, dentists, oral surgeons, veterinarians and other licensed medical professionals with prescribing authority.
II. DEA Certificate of Registration Basics.
Federal law requires that qualified “practitioners” must obtain a DEA Certificate of Registration in order to handle controlled substances. Applicable State laws also govern the scope of controlled substance related activities in which a DEA registered practitioner may engage. Therefore, a practitioner is required to adhere to both Federal and State controlled substance statutes and regulations. To the extent that applicable Federal and State laws are inconsistent or may conflict, a practitioner is required to comply with whichever requirement is more stringent or restrictive.
III. Obtaining Your DEA Certificate of Registration.
If you are reading this, chances are that you are a licensed health care professional who is in the process of seeking to obtain or renew a DEA Certificate of Registration. Is holding a DEA Certification of Registration necessary for you to practice medicine? Not necessarily, but it sure makes helps. Problems encountered if you do not hold a DEA Certificate of Registration may include:
- Barrier to Employment. Employers seeking to hire a licensed medical professional with prescribing authority may be hesitant to select a physician or nurse practitioner applicant who is not authorized to prescribe controlled substances.
- Difficulties Enrolling as a Participating Provider. When completing a credentialing application, the fact that you do not hold a DEA Certification of Registration will likely be flagged by a payor. This can result in delays in the processing of your credentialing application until the payor has a chance to review the reasons why you are not a current registrant. Is it because your application for a DEA Certificate of Registration is pending OR is it because you previously held a DEA Certification of Registration and it was subsequently suspended or revoked?
- Requirement for Hospital Privileges. To obtain privileges you may find that the hospital will not consider your application for privileges if you do not hold a current DEA Certificate of Registration.
For discussion purposes, let’s assume that you are a medical doctor and you are currently licensed to practice medicine in your state by the State Medical Board. As a licensed physician, you likely have the authority to prescribe medications (non-controlled substances) for your patients. If you are seeking to obtain a DEA Certificate of Registration, you must first show that you are currently licensed by your state’s professional licensing authority (typically the State Medical Board for physicians and the State Board of Nursing for nurse practitioners). You must also show that you meet your state’s requirements to prescribe controlled substances.
If you are properly licensed by the State, authorized by the State to prescribe controlled substances, and your prior prescribing history is clean, your application for DEA Certificate of Registration is likely to be approved. However, there are a number of situations that can quickly derail your application. Under 21 USC § 824, your application for a DEA Certificate of Registration may be denied, suspended or revoked if a registrant:
- has materially falsified any application filed pursuant to or required by this subchapter or subchapter II;
- has been convicted of a felony under this subchapter or subchapter II or any other law of the United States, or of any State relating to any substance defined in this subchapter as a controlled substance or a list I chemical.
- has had his State license or registration suspended, revoked, or denied by competent State authority and is no longer authorized by State law to engage in the manufacturing, distribution, or dispensing of controlled substances or list I chemicals or has had the suspension, revocation, or denial of his registration recommended by competent State authority;
- has committed such acts as would render his registration under section 823 of this title inconsistent with the public interest as determined under such section; or
- has been excluded (or directed to be excluded) from participation in a program pursuant to section 1320a-7(a) of title 42.
IV. What Does it Mean if the Issuance of a DEA Certificate of Registration Would be “Inconsistent with the Public Interest”?
There are a number of statutory reasons that may serve as a basis for denying an applicant’s DEA Registration. Of these reasons, the argument that the issuance of a DEA Registration would be “inconsistent with the public interest” is most often cited by the government when a denial has been proposed. What does this mean? Under 21 U.S.C.§ 823(b), the following factors are to be considered when making a determination of whether the issuance of a DEA Registration would be inconsistent with the public interest:
(1) maintenance of effective control against diversion of particular controlled substances into other than legitimate medical, scientific, and industrial channels;
(2) compliance with applicable State and local law;
(3) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;
(4) past experience in the distribution of controlled substances; and
(5) such other factors as may be relevant to and consistent with the public health and safety.
V. What Happens if Your Application for a DEA Certificate of Registration is on Track to be Denied?
After you complete and submit your application for a DEA Certificate of Registration, the agency will conduct a review of your application (along with any other relevant information that it has identified) in order to make a determination of whether your application should be approved. If the Administrator is unable to approve of your application, the Administrator is required to issue an “Order to Show Cause” why your application for registration should not be denied, revoked or suspended. An Order to Show Cause is required to:
(2) An order to show cause under paragraph (1) shall—
(A) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated by the applicant or registrant;
(B) direct the applicant or registrant to appear before the Attorney General at a time and place stated in the order, but not less than 30 days after the date of receipt of the order; and
(C) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before the date of appearance.
(3) Upon review of any corrective action plan submitted by an applicant or registrant pursuant to paragraph (2), the Attorney General shall determine whether denial, revocation, or suspension proceedings should be discontinued, or deferred for the purposes of modification, amendment, or clarification to such plan.
(4) Proceedings to deny, revoke, or suspend shall be conducted pursuant to this section in accordance with subchapter II of chapter 5 of title 5. Such proceedings shall be independent of, and not in lieu of, criminal prosecutions or other proceedings under this subchapter or any other law of the United States.
(5) The requirements of this subsection shall not apply to the issuance of an immediate suspension order under subsection (d).
VI. How Should You Respond to an Order to Show Cause?
After being served with an Order to Show Cause, you will have 30 days to respond. In most cases, you will want to request a hearing. Applicable regulations require that your Request for Hearing be filed in a specific form and include certain information (as set out under 21 C.F.R. § 1316.47(a). A Show Cause hearing is conducted by a DEA Administrative Law Judge. These procedures are conducted in accordance with the Administrative Procedures Act (21 C.F.R. §§ 1316.41-1316.68).
Depending on the facts, you may choose to waive your right to a hearing. Even if that is the case, you will still need to file a written position statements within the 30-day response deadline. Under this scenario, if you have submitted a position statement to be considered, it will be forwarded along with the evidence assembled by the agency to the Administrator. The DEA Administrator will then issue a Final Order based on the information and evidence forwarded by the parties.
Finally, you may decide not to contest the action and not to submit a request for a hearing or a position statement. In such a case, the ALJ assigned to your case will base his decision solely on the evidence assembled by the agency. He will then likely issue a Final Order affirming the agency’s decision to deny your application for a DEA Registration.
VII. What Happens in a DEA Show Cause Hearing?
The purpose of an Order to Show Cause hearing is for an ALJ to review factual evidence regarding the issues involved in your registration denial6. Parties to the hearing present their case or defense by oral and documentary evidence, submit rebuttal evidence, and cross-examine adverse witnesses. Arguments are offered into evidence and presented in opening and closing statements of counsel. The ALJ will also review proposed findings of fact and conclusions of law submitted by the parties. The burden of proof is on the DEA to show, by a preponderance of the evidence, that a violation occurred and that your application for Registration should be denied.
VIII. Suspension of a Practitioner’s DEA Registration.
Pursuant to 21 U.S.C. § 824(d)(1), the Attorney General (through the DEA Administrator), can suspend a registrant’s DEA Certificate of Registration in cases where there is an “imminent danger to the public health and safety.” If a registrant’s DEA Certificate of Registration is suspended, it will continue in effect until administrative and / or judicial proceedings have been completed. During this period, a suspended registrant will not have the authority to prescribe controlled substances. Moreover, a registrant who is suspended on this basis is not eligible to submit a proposed Corrective Action Plan.
IX. Revocation of a Practitioner’s DEA Registration.
A recent amendment to the law (called the Ensuring Patient Access and Effective Drug Enforcement Act of 2016) now allows recipients of an Order to Show Cause (except those also receiving an Immediate Suspension Order) to submit a Corrective Action Plan. A Corrective Action Plan provides an opportunity for the registrant to demonstrate remedial actions contemplated or taken, and requests DEA to discontinue the Order to Show Cause proceedings. What should be discussed or admitted in a Corrective Action Plan, as well when it should be submitted (the law is unclear), is a decision that likely should be made after seeking advice from an experienced attorney.
X. What is a DEA Registration Corrective Action Plan?
As a result of the passage of the Ensuring Patient Access and “Effective Drug Enforcement Act of 2016,” DEA registrants issued an Order to Show Cause became eligible to submit a Corrective Action Plan. A Corrective Action Plan is intended to show the DEA that a registrant intends to take remedial steps that will obviate the need for Order Show Cause proceedings. Pursuant to 21 U.S.C. § 824(c)(3):
Upon review of any corrective action plan submitted by an applicant or registrant pursuant to paragraph (2), the Attorney General shall determine whether denial, revocation, or suspension proceedings should be discontinued, or deferred for the purposes of modification, amendment, or clarification to such plan.
Unfortunately, the statute does not set out how a Corrective Action Plan is to be constructed or discuss how the DEA is to evaluate the plan.
Liles Parker attorneys are experienced in representing physicians, nurse practitioners and other DEA registrants in administrative proceedings. For a complimentary consultation, give us a call at (202) 298-8750.
 The Controlled Substances Act (CSA), Pub.L. 91-513; 84 Stat 1236., was enacted on May 1, 1971. Its provisions are codified in 21 U.S.C., Chapter 13 §801 et seq. Since enacted, the CSA has been amended almost a dozen times.
 Under 21 U.S.C. § 802(6), the term “Controlled Substance” is defined as:
“A drug [the term “drug” has the meaning of that term set out in § 321(g)(1) of this chapter] or other substance, or [as defined in 21 U.S.C. § 802(23)], included in schedule I, II, III, IV, or V of part B of this subchapter [21 U.S.C. Subchapter I – Control and Enforcement]. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986.”
 Under 21 U.S.C. § 802(21), the term “practitioner” is defined as:
“(21) The term "practitioner" means a physician, dentist, veterinarian, scientific investigator, pharmacy, hospital, or other person licensed, registered, or otherwise permitted, by the United States or the jurisdiction in which he practices or does research, to distribute, dispense, conduct research with respect to, administer, or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.”
 21 U.S.C. § 1309.46.
 Under 21 U.S.C. § 824(d)(2), the phrase “imminent danger to the public health or safety” means that:
due to the failure of the registrant to maintain effective controls against diversion or otherwise comply with the obligations of a registrant under this subchapter or subchapter II, there is a substantial likelihood of an immediate threat that death, serious bodily harm, or abuse of a controlled substance will occur in the absence of an immediate suspension of the registration.
 The ”Ensuring Patient Access and Effective Drug Enforcement Act of 2016” was signed into law by President Obama on April 19, 2016. The law modified the Controlled Substance Act. Although the statute sailed through Congress and was signed without fanfare by President Obama, the statute’s provisions have since proven to be quite controversial.
 Under 21 U.S.C. § 824(c)(5), a registrant whose DEA Certificate of Registration has been suspended due to an “imminent danger to the public health or safety” (See 21 U.S.C. § 824(d)(1)), is not eligible to submit a Corrective Action Plan.